首页 > 市场调查报告书 > 医疗设备

e保健远距离医疗

市场调查报告书

商品编码

1678797

日本远距医疗市场 - 2025 - 2033

Japan Telemedicine Market - 2025-2033

出版日期: 2025年03月11日 | 出版商:

DataM Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年日本远距医疗市场规模达到 51.4291 亿美元，预计到 2033 年将达到 258.6749 亿美元，2025-2033 年预测期内的复合年增长率为 19.5%。

远距医疗是一种远距医疗服务方式，利用电信技术为患者提供医疗建议、诊断和治疗计画。它解决了医疗保健获取方面的障碍，如地理距离、时间限制和患者流动性问题。远距医疗对于医疗保健人员短缺的农村地区尤其有益。随着科技的进步，远距医疗融合了远端监控、人工智慧诊断和行动健康专业领域等工具，成为数位医疗革命的关键部分。

市场动态：

驱动因素与约束因素

日本人口老化和远距医疗需求不断增长

日本远距医疗市场受到人口老化和远距医疗需求不断增长的推动。日本65岁以上的人口比例大，糖尿病、高血压、心血管病等慢性病发生率都很高。远距医疗提供了一种便捷的解决方案，特别是对于偏远地区的老年人来说。远端咨询和监控系统弥合了患者和医疗保健提供者之间的差距，确保及时护理并减少医院就诊次数。对远距医疗的依赖不断增加，推动了日本市场的成长。

例如，日本的住院护理需求预计将在2040年达到峰值，从而导致医疗和福利工作者在2035-2040年间成为最大的产业。预计2040年医疗卫生支出将达到89兆日圆，比2023年高出1.6倍，造成27兆日圆的财政缺口。为了维持现有的医疗保健水平，政府可能需要减少低价值护理，将任务从医生转移到其他职业，并透过数位转型提高效率。

监管挑战和资料隐私问题

由于严格的医疗保健法规，日本远距医疗市场面临监管挑战和资料隐私问题。虽然远距医疗可以改善医疗服务，但这些规定限制了数位健康解决方案的广泛采用。远距医疗平台必须遵守病患保密、资料安全和许可要求。确保个人健康资料的安全传输和储存是一个主要问题，尤其是在网路安全威胁日益加剧的情况下。这种复杂的监管环境可能会减缓日本远距医疗服务的成长。

Telemedicine is a remote healthcare delivery method that uses telecommunications technology to provide medical advice, diagnoses, and treatment plans to patients. It addresses barriers to healthcare access like geographical distance, time constraints, and patient mobility issues. Telemedicine is particularly beneficial in rural areas with healthcare workforce shortages. As technology advances, telemedicine incorporates tools like remote monitoring, AI-driven diagnostics, and mobile health Speciality Areas, making it a key part of the digital healthcare revolution.

Market Dynamics: Drivers & Restraints

Aging Population and Rising Remote Healthcare Demand in Japan

The Japan telemedicine market is driven by the aging population and increasing demand for remote healthcare. With a significant percentage of the population aged 65 and above, Japan is facing a high incidence of chronic conditions like diabetes, hypertension, and cardiovascular diseases. Telemedicine offers a convenient solution, especially for elderly individuals in remote areas. Remote consultations and monitoring systems bridge the gap between patients and healthcare providers, ensuring timely care and reducing hospital visits. This increased reliance on telemedicine is driving market growth in Japan.

For instance, Japan's inpatient care demand is expected to peak by 2040, leading to medical and welfare workers becoming the largest industry by 2035-2040. Healthcare expenditures in 2040 are projected to reach ¥89 trillion, 1.6 times higher than in 2023, causing a ¥27 trillion financial shortfall. To maintain current medical care levels, the government may need to reduce low-value care, shift tasks from physicians to other professions, and improve efficiency through digital transformation.

Regulatory Challenges and Data Privacy Concerns

The Japan telemedicine market faces regulatory challenges and data privacy concerns due to strict healthcare regulations. While telemedicine can improve healthcare access, these regulations limit the widespread adoption of digital health solutions. Telemedicine platforms must comply with patient confidentiality, data security, and licensing requirements. Ensuring secure transmission and storage of personal health data is a major concern, especially amid rising cybersecurity threats. This complex regulatory landscape could slow telemedicine service growth in Japan.

Segment Analysis

The Japan telemedicine market is segmented based on type, specialty area, and end user

Type:

mHealth in the type segment is expected to dominate with the highest market share

Mobile health (mHealth) is a key in Japan's telemedicine landscape, enhancing accessibility, efficiency, and patient engagement. It enables remote monitoring, virtual consultations, and chronic disease management through smartphones and wearable devices. It supports the aging population by enabling real-time health tracking and medication adherence. mHealth integrates with EHRs and AI for improved diagnostic accuracy and personalized treatment plans. Government initiatives and regulatory support drive its expansion.

End User:-

Hospitals are expected to dominate the end-user segment with the highest market share.

The hospital segment is the fastest-growing segment in the telemedicine market share and is expected to hold the market share over the forecast period.

Japan's hospitals are integrating digital health solutions into their services, particularly in rural areas with limited resources. They are using telemedicine platforms to provide remote consultations, specialist access, and follow-up care to patients who cannot visit in person. This reduces wait times and alleviates pressure on staff and infrastructure. Telemedicine is also being used to improve patient monitoring for chronic conditions. As Japan's healthcare system transitions towards patient-centered care, telemedicine is being increasingly adopted to enhance efficiency, reduce readmissions, and improve patient outcomes.

Competitive Landscape

The major country players in the Telemedicine market include Nihon Kohden Corporation, MEDLEY, INC, Terumo Corporation, M3, Inc, Medmain, PK Telehealth, NTT Data Inc, Sony Corporation, and others.

Key Developments

In April 2024, Japan's internal affairs ministry launched an initiative to offer online doctor consultations and medication guidance through private booths at post offices, with drugs delivered via postal service.
In June 2024, Infosys partnered with Japan's dispensing pharmacy chain, Nihon Chouzai, to improve healthcare access in Japan. The partnership includes the development of a mobile application, NiCOMS, which offers remote medication guidance from registered pharmacists, eliminating the need for pharmacy visits.

Why Purchase the Report?

Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth countries and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.

The Japan Telemedicine market report delivers a detailed analysis with 33 key tables, more than 27 visually impactful figures, and 140 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Speciality Area & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Specialty Area
3.3. Snippet by End User

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Aging Population and Rising Remote Healthcare Demand in Japan
- 4.1.2. Restraints
  - 4.1.2.1. Regulatory Challenges and Data Privacy Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. mHealth*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Tele Hospitals/Clinics
6.4. Telehome

7. By Specialty Area

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specialty Area
- 7.1.2. Market Attractiveness Index, By Specialty Area
7.2. Dermatology*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cardiology
7.4. Gynecology
7.5. Psychiatry
7.6. Trauma Care
7.7. Others

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics
8.4. Others

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

10.1. Nihon Kohden Corporation*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio
  - 10.1.2.1. Product Description
  - 10.1.2.2. Product Key Performance Indicators (KPIs)
  - 10.1.2.3. Historic and Forecasted Product Sales
  - 10.1.2.4. Product Sales Volume
- 10.1.3. Financial Overview
  - 10.1.3.1. Company Revenue's
  - 10.1.3.2. Geographical Revenue Shares
  - 10.1.3.3. Revenue Forecasts
- 10.1.4. Key Developments
  - 10.1.4.1. Mergers & Acquisitions
  - 10.1.4.2. Key Product Development Activities
  - 10.1.4.3. Regulatory Approvals, etc.
- 10.1.5. SWOT Analysis
10.2. MEDLEY, INC
10.3. Terumo Corporation
10.4. M3, Inc
10.5. Medmain
10.6. PK Telehealth
10.7. NTT Data Inc
10.8. Sony Corporation
Similar data will be provided for each market player.